Johnson & Johnson (JNJ)
218.66
-0.91
(-0.41%)
USD |
NYSE |
Jan 16, 16:00
218.75
+0.09
(+0.04%)
Pre-Market: 20:00
Johnson & Johnson Free Cash Flow: 20.46B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Intuitive Surgical, Inc. | 2.271B |
| Eli Lilly & Co. | 6.436B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 9.169B |
| Cash from Investing (Quarterly) | -542.00M |
| Cash from Financing (Quarterly) | -8.927B |
| Free Cash Flow Per Share (Quarterly) | 3.292 |
| Free Cash Flow to Equity (Quarterly) | 12.96B |
| Free Cash Flow to Firm (Quarterly) | 8.255B |
| Free Cash Flow Yield | 3.86% |